You are here > News and publications

News and publications

Promethera Biosciences is establishing its large scale manufacturing unit for late clinical and commercial batches of HepaStem

12/06/2013

Gosselies (Belgium) – June 12, 2013 - The foundation stone of the Walloon Cell Therapy Platform in Gosselies (Belgium) was laid in presence of Mr. J.-C. Marcourt, Vice President and Minister of the Economy, SMEs, Foreign Trade and New Technologies of the Walloon Region and Mr. J.-M. Nollet, Vice President and Minister for Sustainable Development, Public Administration and Energy, Housing and Research in the Walloon Region. The total investment of EUR 20 million is financed by a Public-Private Partnership.

 

This platform will allow large-scale production of cell therapy medicines and has been established thanks to a public-private partnership. The Walloon Region and Sambrinvest contribute to the industrial renewal of the region and two private Cell Therapy Companies - Promethera Biosciences and Bone Therapeutics – invest.

 

Promethera Biosciences will start its large-scale production from 2015. 

 

Download the file (EN)

Contacts

PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
(Belgium)
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea